MedTrace Logo

Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography

NCT00541801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2011-06-27

No results posted yet for this study

Summary

In this study, the investigators sought to determine whether an acoustic cardiographic assessment of heart function is equivalent to Doppler-echocardiography in patients who are treated with cardio-toxic cytostatic agents.

Conditions

  • Heart Failure, Congestive
  • Antineoplastic Agents

Interventions

DEVICE

Doppler-echocardiography and acoustic cardiography

Patients receive a Doppler-echocardiography and an acoustic cardiography

Sponsors & Collaborators

  • Inovise Medical

    collaborator INDUSTRY

  • Luzerner Kantonsspital

    lead OTHER

Principal Investigators

  • Paul Erne, MD · Luzerner Kantonsspital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00541801 on ClinicalTrials.gov